Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NGVT | Employee Stock Option (right-to-buy) | Award | $0 | +7.2K | +38.21% | $0.00 | 26K | Feb 26, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NGVT | Employee Stock Option (right-to-buy) | Award | $0 | +4.14K | $0.00 | 4.14K | Feb 26, 2021 | Common Stock | 4.14K | $69.48 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | The reporting person's Form 4 filed with the SEC on March 2, 2021 inadvertently reported an incorrect vesting schedule for restricted stock units granted on February 26, 2021 pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. The restricted stock units will vest on February 26, 2024. This amendment is being filed to correct: (a) the vesting schedule for this grant; (b) the exercise price for an Employee Stock Option (right-to-buy) addressed in Footnote 2, below; and (c) to correct the signature line of the prior report. |
F2 | The reporting person's Form 4 filed with the SEC on March 2, 2021 inadvertently reported an incorrect exercise price with respect to the Employee Stock Option (right-to-buy). |
F3 | These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options will vest ratably beginning February 26, 2022, 2023 and 2024. |